Christopher Posner - Feb 2, 2023 Form 4 Insider Report for Cara Therapeutics, Inc. (CARA)

Role
President and CEO, Director
Signature
/s/Darren DeStefano, Attorney-in-Fact
Stock symbol
CARA
Transactions as of
Feb 2, 2023
Transactions value $
-$49,454
Form type
4
Date filed
2/3/2023, 05:38 PM
Previous filing
Nov 30, 2022
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CARA Common Stock Sale -$49.5K -4.19K -2.25% $11.80 182K Feb 2, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units reported in the Form 4 filed with the Securities and Exchange Commission on November 3, 2021 and does not represent a discretionary trade by the Reporting Person.